Search
Close this search box.
Bravado Health’s EPCS Certification Success with Drummond

Bravado Health’s EPCS Certification Success with Drummond

Bravado Health Gives Customers Confidence with EPCS Certification

Challenge

In 2012, the year after the Drug Enforcement Administration (DEA) approved electronic prescribing of controlled substances (EPCS), EPCS adoption was very low. In fact, only several states allowed EPCS. Nevertheless, Bravado Health, recognized the importance of EPCS and looked for an auditor that was approved by the DEA. Drummond was one of the first to have their EPCS certification process approved by the DEA. To meet the new EPCS 21 CFR 1311 requirements, Bravado Health turned to Drummond as a trusted partner. Bravado Health had previously engaged Drummond for ONC EHR certification and was impressed by Drummond’s attention to their customers. As Drummond’s first EPCS client over eight years ago, Bravado Health has maintained certification with Drummond for EPCS compliance to mitigate risks for their customers.

Approach

Drummond’s EPCS certification process, with a strong emphasis on requirements review, was essential in guiding Bravado Health through the complicated detail in 21 CFR 1311 Final Rule for EPCS. With this clear understanding of the DEA’s requirements, Bravado Health in turn had confidence to start development of the application requirements in their product. This guidance allowed Bravado Health to save many hours of research and to begin development sooner. During the development process Drummond scheduled regular meetings to address ongoing questions, as well as provided technical expertise on two-factor authentication, identify proofing, biometrics, and security and digital certificates.
“While our work doesn’t touch patients directly, you can’t overestimate the value of verified HIPAA compliance to a hospital executive. It’s a credential that adds to our credibility. The fact that Mendix has third-party HIPAA validation is an important plus for us and our clients.”

Richard D. Palarea, CEO
Kermit

Bravado Health white logo.

Results

Drummond’s EPCS certification process, with a strong emphasis on requirements review, was essential in guiding Bravado Health through the complicated detail in 21 CFR 1311 Final Rule for EPCS. With this clear understanding of the DEA’s requirements, Bravado Health in turn had confidence to start development of the application requirements in their product. This guidance allowed Bravado Health to save many hours of research and to begin development sooner.

During the development process Drummond scheduled regular meetings to address ongoing questions, as well as provided technical expertise on two-factor authentication, identify proofing, biometrics, and security and digital certificates.

About Bravado Health

Bravado Health was founded by physicians and engineers in 1998 to streamline the discharge process. From its origin in discharge technology, Bravado Health expanded its portfolio to patient engagement and web-based applications. Today, Bravado Health provides solutions for some of the nation’s most recognizable and innovative healthcare organizations. Bravado Health’s newest platform, Ayva, extends beyond the point of care by offering web-based health experiences.

Drummond is ready to help you incorporate continuous security and compliance practices into your organization and culture. Experience our team of highly skilled experts ready to collaborate with you and your team. Increase trust, gain expertise and experience our unique approach and attention to detail as we partner with you to achieve compliance, application conformance and protect your business with advanced cyber-security practices.

Electronic Prescriptions for Controlled Substances (EPCS) is a Federal Rule which allows for the electronic transmission of prescriptions of Controlled Substances. In response to the rising prescription drug abuse problem, the US Drug Enforcement Administration (DEA) and states worked together to create programs and legislation to deter abuse and misuse. EPCS has mandates at the national and local levels governed by the DEA to reduce the potential for diversion, and subsequent abuse of controlled substances.

The DEA Title 21 CFR provides guidance for EPCS. EPCS technology is addressing the problem of forged or stolen prescriptions by requiring authentication of prescribers, improving security standards, and auditing activity on EPCS platforms. States that mandate this today include New York, Maine, Connecticut and Pennsylvania. By 2022 half the states in the US will mandate EPCS certification.

Ready to learn how Drummond can help you
become EPCS certified?

Download Drummond's Guide to Integration Review of E-Prescription Module

Please fill out the form below to download the guide.

[gravityform id="66" title="false" description="false" ajax="true"]

Drummond's guide to EPCS Recertification

Please fill out the form below to download the guide.

[gravityform id="65" title="false" description="false" ajax="true"]

Drummond's guide to Initial EPCS Certification

Please fill out the form below to download the guide.

[gravityform id="64" title="false" description="false" ajax="true"]